Clinical Trial Update: Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for KP-100IT in acute spinal cord injury; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• KP-100IT

Snippet

Sponsor: Kringle Pharma, Inc. | Conditions: Acute Spinal Cord Injury | Phase 3 | Status: UNKNOWN